Published in Vaccine Weekly, August 23rd, 2006
DPP is a new and innovative rapid chromatographic immunoassay platform that Chembio believes improves sensitivity in single and multiple parameter tests as compared to standard single-path lateral flow assays. The improved sensitivity results from increased efficiency of antibody binding to the immobilized test antigen, enabled by the use of an independent sample flow path for the delivery of all sample types, including oral fluid samples.
Chembio has already...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly